The federal Medicare-Medicaid office that cooks up new projects has a new face as of April 9.
Adam Boehler, the founder and CEO of a home-based medical care company, will head the agency’s Center for Medicare & Medicaid Innovation, known as CMMI.
The four dozen or so active payment and service demonstrations under the office’s bailiwick range from the small—the Vermont All-Payer Accountable Care Organization, for example—to the more ambitious, such as the nationwide pre-diabetes prevention program.
Boehler will have to face such decisions as whether CMMI should develop a model to evaluate the exclusive use by the pre-diabetic participants of virtual services for the lessons, rather than coming to a classroom. The model would be part of efforts to promote access to telehealth services.
“Medicare innovation” has a positive ring but it hasn’t all been a bed of roses.
The CMMI caught the harsh glare of the spotlight when it proposed a large mandatory demonstration to test different methods to pay for Medicare beneficiaries’ drugs given in a doctor's office. The model was the subject of thousands of comments, mostly negative, and was never put in place.
It particularly ticked off former Health and Human Services Secretary Tom Price who said the center was “off track” and had “mandatorily been dictating to physicians how they must practice.”
The Trump administration has been focusing more on voluntary projects at the request of industry groups.
The agency in September asked the public for input on a new direction for the center. The focus was to be on eight areas, from increasing opportunities for doctors to participate in alternative payment models to ways to reduce fraud, waste, and abuse.
Although he hadn’t previously worked for the government, Boehler appears to be a good fit for an office that cooks up health-care delivery projects.
He co-founded Landmark Health, a company focused on delivering medical services to chronically ill patients.
He also founded Avalon Health Solutions, a laboratory benefit management services company, the HHS said in the announcement.
Read my full story here.
Stay on top of new developments in health law and regulation, and learn more, by signing up for a free trial to Bloomberg Law.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)